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emerging class of small RNA regulators of gene expression. Evidence supporting interactions
between microRNAs and nuclear receptors in the regulation of gene expression networks is dis-
cussed in relation to its possible role in neural stem cell self renewal and differentiation. Further-
more, we discuss possible disturbances of the regulatory loops between microRNAs and nuclear
receptors in human neurodegenerative disease. Finally, we discuss the possible use of nuclear recep-
tors as pharmacological entry points to regulate neural stem cell self-renewal and differentiation.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nuclear receptors (NRs) are ligand-activated transcription fac-
tors that regulate the expression of target genes by binding to
cis-acting sequences present in the DNA. NRs represent a large
family of genes encoding receptors for various ligands, including
thyroid hormones, retinoic acid, vitamin D and steroid hormones.
In addition, based on sequence similarity to well-characterized
NRs, numerous putative ‘‘orphan’’ NRs have been described, for
which no ligand has yet been identiﬁed. Thus, the NRs comprise
a superfamily of phylogenetically related proteins with diverse
functions that are involved in regulation of development, differen-
tiation, reproduction and homeostasis. By acting as ligand-acti-
vated transcription factors, NRs control the expression of groups
of responsive genes. Members of the NR superfamily include
well-known nuclear hormone receptors, such as the estrogen
receptor (ER), the androgen receptor (AR), the progesterone recep-
tor (PR) and the glucocorticoid receptor (GR) among others, the
metabolic receptors such as the peroxisome proliferator-activated
receptors (PPARs) alpha, beta/delta and gamma, and the liver X
receptor (LXR) among others, as well as orphan receptors [1]. An
example of the orphan receptors is the nuclear receptor homologuechemical Societies. Published by E
science, Swammerdam Insti-
cience Park 904, 1098 XH
ons).of the Drosophila tailless gene (TLX). TLX plays an important role in
various vertebrate brain functions and regulates the timing of neu-
rogenesis in neural stem cells (NSC) [2].
NRs, through their function as specialized ligand-induced tran-
scription factors are key components of transcriptional regulatory
networks in several tissues. Particularly, the brain is an important
target of NR action and most of the family members are
expressed in this tissue. 41 out of 49 NRs have been speciﬁcally
detected in different brain areas, suggesting that NRs are centrally
positioned within regulatory networks that control relevant brain
functions [3].
Modulation by small non-coding RNAs represents a new level of
control of gene expression. The recently discovered small non-cod-
ing RNAs are generally classiﬁed into endogenous small interfering
RNAs (siRNAs), microRNAs (miRNAs) and piwi-interacting RNAs
(piRNAs). In particular, miRNAs and piRNAs have been implicated
in various aspects of animal development, such as neuronal, mus-
cle and germline development [4]. miRNAs are endogenous, short,
21–24 nucleotide-long non-coding RNAs that are expressed in a
tissue-speciﬁc and developmentally-regulated manner. They func-
tion as negative regulators of gene expression in a variety of
eukaryotic organisms by speciﬁcally binding to mRNAs, which re-
sults in cleavage or translation inhibition of the target and thereby
ﬁne-tune protein expression. These small RNA regulators are in-
volved in numerous cellular processes including development, pro-
liferation, differentiation and cell fate decisions [5]. Moreover,
miRNAs are key elements in controlling post-transcriptional genelsevier B.V. All rights reserved.
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works [6]. Interestingly, recent theoretical models have suggested
that miRNAs confer redundancy to transcription factor networks.
This reduces the repertoire of transcription factor target genes
and places miRNAs in a good position to coordinate and inﬂuence
gene expression network regulation [7].
In the following sections, evidence supporting an interaction
between miRNAs and NRs in the regulation of gene expression net-
works will be presented and discussed in relation to its possible
role in neural stem cell self renewal and differentiation and associ-
ation with human neurodegenerative diseases.
2. Interactions between miRNAs and NRs in the regulation of
gene-expression networks by reciprocal expression control
Beyond the phylogenetical relationships mentioned in the pre-
vious section, a functional convergence of NRs is also apparent in
controlling morphogenesis and homeostasis by regulating gene-
expression networks [1]. A recently emerging pattern within the
NR family seems to be the ability to regulate, and in turn to be reg-
ulated by, miRNAs at different levels, in what has been deﬁned as
‘‘regulatory loops’’ [8]. Regulatory feedforward and feedback loops
involving miRNAs are common features of transcription-factor reg-
ulated gene-expression networks (see [7,8] and references there-
in). For the orphan NRs, where the complexity of ligand
modulation is disregarded, it has been proposed that regulatory
loops involving miRNAs may have central roles in controlling
cell-intrinsic pathways involved in key cellular functions. In partic-
ular, miR-9 is expressed preferentially in neurogenic areas of the
brain and has been implicated in neural stem cell self-renewal
and differentiation [9]. The orphan NR TLX, forms a negativeA
B
Fig. 1. NR as spatial and temporal orchestrators of miRNA expression during stem cell
miRNAs could act as controllers of regulatory loops involving transcription factors [4
components, the protein component (representing the transcription factors (TF)) and th
positively on itself. The protein component in Step 1 is target of miRNA inhibition. Step 2
the model presented in A, to accommodate hormone-induced NR action. This extension is
and proposes that NRs for steroid hormones may act as regulators of self-renewal, cell-fa
model, a positive regulatory feedback loop involving NRs and miRNAs, is depicted. The X
(left), low levels of NR activity under conditions of low hormone stimulation are present
peak (center), the effect of sustained hormonal activation (full lines) overcomes miRNA-
and thereby transcription of its responsive genes. Additionally, the decrease in miRNA exp
hormone-responsive. Once the hormone peak has receded, the system returns to its basal
different from the one in the previous cycle, due to the expression of hormone-responsregulatory loop with miR-9, and thereby inﬂuences the balance
between NSC proliferation and differentiation. In NSCs miR-9,
among other functions, represses TLX expression, which results
in a negative regulation of NSC proliferation and accelerated neural
differentiation. Reconstitution of TLX function rescues miR-
9–induced proliferation deﬁciency and inhibits precocious
differentiation, underscoring the relevance of the regulatory loop
involving TLX and miR-9 in orchestrating precise control of gene
expression during NSC renewal and differentiation [10].
With respect to the ligandedNR, regulatory loops involvingmiR-
NAs were recently demonstrated as well. Interestingly, many of
these examples involve NRs for steroid hormones. This may be
either related to a common theme in their regulatory mechanisms
or to themere fact that they have beenmore extensively studied. As
wewill discuss below,many of the studies exploring the interaction
betweenmiRNAs and liganded NRs have focused on the NRs for ste-
roid hormones. As an extensive review of the relationships between
NRs for steroid hormones and miRNAs was recently published [11],
we will here concentrate on some well-characterized members of
this NR family with known functions on NSCs, anticipating that in
the future some of the observations and conclusions based on them
will be extended also to other members of the NR family.
In Drosophila melanogaster, the steroid hormone ecdysone and
its cognate receptor EcR regulate developmental progression [12].
This regulation is at least in part exerted via a positive autoregula-
tory loop involving EcR and miR-14 that controls steroid hormone
signaling (Fig. 1). Ecdysone activates EcR, which stimulates EcR
transcription. miR-14 modulates this loop by limiting expression
of its target, i.e. the EcR. In turn, ecdysone-stimulated EcR down-
regulates miR-14, which alleviates miR-14 repression of EcR and
hence ampliﬁes the response [13].self-renewal and differentiation. (A) A theoretical model proposed to explain how
9]. The scheme shows an example of a negative feedback loop reduced to two
e miRNAs component. Step 1 represents the TF positive action that may feedback
represents the TF-induced transcription of the miRNA component. (B) Extension of
based on experimental data obtained with the steroid hormone receptor EcR [12,13]
te determination and differentiation by modulating miRNA activity. In this extended
–Y axis graph represents a hypothetical cycle of hormone action. In basal conditions
(dashed lines) and repression by miRNA dominates (full line). During the hormone
mediated repression (dashed lines), allowing for a strong (auto)activation of the NR
ression induced by the hormone peak may affect other genes, which are not directly
state (right), where repression by miRNA dominates. Nevertheless, this basal state is
ive genes during the previous peak.
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steroidal ligands, the dafachronic acids, control accurate progres-
sion of cell division and differentiation events during development.
This control is exerted through a feedback loop between DAF-12
and the let-7-family miRNAs involving both the repression of
DAF-12 by let-7-family miRNAs and transcriptional activation
and repression of the let-7-family miRNAs by activated DAF-12.
Thereby, during C. elegans development, microRNAs and NRs are
components of a hormone-coupled molecular switch that shuts
off earlier developmental programs to allow for later ones [14].
In mammalian cells, activation of the ER alpha induces expression
of a characteristic miRNA proﬁle, or ‘‘microRNA signature’’, that
regulates ER alpha expression and its transcriptional response in
a characteristic inhibitory feedback loop that may coordinate cellu-
lar responses to estrogens [15]. Also, recent observations demon-
strate ER alpha to be involved in a positive feedback loop with
miR-375, triggered by loss of epigenetic marks in human breast
cancer cells [16].
Importantly, similar regulatory loops involving NRs and miR-
NAs have been intensively studied in cancer and metabolism.
Therefore, extrapolation of some of the concepts learned from
these systems could provide conceptual grounds to understand
putative roles in other proliferative cells, such as NSCs. An over-
view of the vast literature describing the interplay between NRs
(i.e. for steroid hormones) and miRNAs in various cancers is be-
yond the objective of this minireview and we refer to a recent re-
view on this topic [17].
As discussed before, the mutual regulation between miRNAs
(e.g., miR-375) and ER has been established in human breast cancer
[16]. Moreover, the role of AR and other NRs in regulating microR-
NAs expression (e.g. mir-21 and mir-101) in prostate cancers (re-
cently reviewed in [18]), is under intense investigation. Recent
data suggest that regulatory interactions between the ER, AR, PR
and GR and miRNAs may contribute to disease progression in hor-
mone-responsive cancers [17]. As some of these NRs for steroid
hormones and their regulatory miRNAs may be co-expressed in
NSCs, the regulatory loops initially identiﬁed in cancer cells may
become a useful guide to understand their possible roles in NSC
regulation. Examples are presented in the following sections.
The NR Farnesoid X Receptor (FXR), is involved in the regulation
of lipid homeostasis [1]. Recent evidence has shown the existence
of an elaborate positive regulatory loop involving FXR, miR-34a
and the NAD+-dependent deacetylase SIRT1. FXR inhibits tran-
scription of the miR-34a gene, resulting in positive regulation of
hepatic SIRT1 levels. In turn, SIRT1-mediated deacetylation of
FXR increases binding of the FXR/RXR heterodimer to DNA, result-
ing in further repression of miR-34a expression [19]. Dysregulation
of this feedforward loop due to elevated miR-34a levels may have
serious implications for metabolic diseases [20]. Interestingly, in
the adult hippocampus, miR-34a regulates glutamate metabotro-
pic receptor 7 (mGluR7) levels while miR-34a may contribute to
neurogenesis and neuronal structure remodeling [21]. This sug-
gests that the feedforward loop involving FXR and mir-34a identi-
ﬁed in liver may also have interesting implications in the brain,
where gene expression studies have already identiﬁed the expres-
sion of some FXR isoforms [3].
One emerging pattern from the observations described above
seems to be that regulatory loops comprising miRNAs and NRs
control gene-expression networks involved in the spatio-temporal
coordination of essential cell functions such as proliferation, fate
determination and differentiation. In particular, for the NRs for ste-
roid hormones this is highly reminiscent of the classical role pro-
posed for hormonal action, which is to coordinate growth and
development, tissue function, metabolism and other important
systemic functions in multicellular organisms. On the other hand,
miRNAs play an important role in repressing or promoting cell-fateregulators in a stage-speciﬁc manner [22]. In fact, the role for NRs
in controlling the outcome of gene expression regulatory loops
involving miRNAs that we propose here, is coherent with the ac-
cepted function of steroid hormones as coordinators of local cellu-
lar events with ‘‘systemic needs’’, through the activation of their
cognate receptors [1].
Therefore, based on the published evidence discussed above, we
propose that regulatory loops between NRs and miRNAs provide
entry points for cell-extrinsic factors to impact on miRNAs, thereby
orchestrating cell proliferation, fate determination and differentia-
tion in time and space (Fig. 1). This hypothesis will be discussed in
more extension in the following sections, with particular focus on
NSCs.3. Interactions between miRNAs and NRs in the regulation of
gene-expression networks at other levels
The concerted action of protein co-regulators known as co-
activators or co-repressors is required for accurate regulation of
gene-expression networks by NRs. Interestingly, several miRNAs
have been demonstrated to target various NR co-regulators as well
(recently reviewed in [18]). These observations suggest that
miRNAs may exert coordinating and redundancy-limiting actions
on gene-expression networks controlled by NRs, not only by
targeting the NRs directly but also indirectly by targeting key
factors that control NRs action, i.e. NR co-regulators.
Another very interesting level of interaction between miRNAs
and NRs is the regulation of miRNA biogenesis by NR. Two paradig-
matic members of the steroid receptor family, i.e. ERa and the GR,
have been shown to regulate miRNA biogenesis at different levels.
ERa controls miRNA maturation by regulating the activity of Dro-
sha, one of the key enzymes involved in the production of mature
miRNAs from their precursors [23]. GR also modulates miRNA
expression and processing by controlling the expression of several
key miRNA processing enzymes; Dicer, Drosha and DGCR8/Pasha
[24]. Although these observations are still restricted to some par-
ticular tissues or cell types, the emerging pattern seems to be that
NRs for steroid hormones may be crucial in the post-transcrip-
tional regulation of microRNA expression, favoring the functional
expression of miRNA sets or ‘‘signatures’’ involved in the coordina-
tion of gene-expression networks [15].4. miRNA-NR interactions in neural stem cells and possible
implications for neurodegenerative diseases
Stem cells are unspecialized cells with the potential ability to
become functionally specialized. They are deﬁned by their ability
to self-renew and their capacity to generate various types of differ-
entiated progeny. Their functional differentiation is governed by a
network of cell-intrinsic cues such as the transcription factor Sox2
(Sex determining region of Y chromosome-related high mobility
group box 2) and the Drosophila membrane-associated protein
Numb homologs and cell-extrinsic signals, such as vascular endo-
thelial growth factor (VEGF), Eph/ephrin signaling molecules and
epithelial- and brain derived-growth factors (EGF and BDNF)
[25], just to mention some prominent examples of cell-intrinsic
and extrinsic factors which impact NSC physiology.
Stem cell therapy is already applied in human patients through
the transplantation of donor bone marrow stem cells or umbilical
cord stem cells into the circulatory system of leukemia patients.
Another therapeutic use of stem cells may come from their direc-
ted differentiation into other cell types, also known as trans-
differentiation. In terms of pharmacological approaches to generate
deﬁned lineages from small populations of stem cells, members of
the NR family seem very interesting candidates because of their
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cell types and in their relatively well-known pharmacology [26].
Due to their ability to inﬂuence signaling pathways and gene tran-
scription, NRs regulate key functions of stem cells. NRs play an
important role in the maintenance of pluripotency (ERRbeta,
SF-1, LRH-1, DAX-1) repression of the stem cell phenotype (RAR,
RXR, GCNF) and differentiation of stem cells (LXR, PPARgamma)
[27].
Remarkably, a central role for miRNAs in core regulatory net-
works underlying stem cell self-renewal, pluripotency and differ-
entiation has started to emerge. Particularly, in NSCs a number of
observations have suggested that self-renewal and differentiation
involves the dynamic interaction between transcription factors,
epigenetic control, miRNA regulators and cell-extrinsic signals
([28] and references therein). Therefore, we will now focus on NSC
and discuss examples of regulatory loops involving miRNAs and
NR that may control self-renewal and the differentiation of NSC.
Recently, NSC-based approaches have received much attention
as potential treatment for neurodegenerative disorders. Transplan-
tation of stem cells in animal models of neurodegenerative dis-
eases can, under speciﬁc conditions, improve function by
replacing the lost neurons and glial cells and by mediating remye-
lination, trophic factor actions and modulation of inﬂammation.
Endogenous NSCs are also potential therapeutic targets, because
they produce neurons and glial cells in response to injury and
could be affected by the degenerative process. Therefore, restora-
tion of damaged neural tissue through the use of exogenous or
endogenous NSCs would be an exciting therapeutic option, if one
could control their proliferation, migration and differentiation
according to speciﬁc tissue repair demands [29].
The generation of neurons during mammalian embryonic brain
development involves a switch of NSCs from proliferation to differ-
entiation. Ablation of Dicer, a key enzyme for miRNA biogenesis in
mammals, during embryonic brain development has demonstrated
that miRNAs are essential for survival and differentiation of new-
born neurons [30]. Moreover, embryonic and adult NSCs frequently
undergo asymmetric cell divisions, generating a variety of neuro-
nal and glia lineages necessary for building functional neural tis-
sue. Cell identity is acquired in different brain structures
according to a stereotyped timing schedule where miRNAs seem
to play an important role by repressing transcription factors in-
volved in cell-fate and proliferation-rate regulation [31].
Several individual miRNAs, including miR-124 and miR-9
among others, have been associated with regulation of neurogene-
sis from NSCs (recently reviewed in [32]). As mentioned before,
miR-9 is expressed preferentially in neurogenic areas of the brain
and is engaged in a regulatory loop with TLX, mutually controlling
their expression levels in NSCs and regulating self-renewal and dif-
ferentiation. MiR-124, one of the most abundant miRNAs in the
adult brain, is an important regulator of the temporal progression
of adult neurogenesis, particularly from NSCs present in the sub-
ventricular zone. Knockdown of endogenous miR-124 expression
maintains NSCs as dividing precursors, whereas ectopic expression
leads to precocious and increased neuronal differentiation, i.e. by
antagonizing the anti-neural REST/SCP1 pathway [33,34].
As discussed in previous sections, the existence of regulatory
feedback loops linking miRNAs to transcription factors expression
and vice-versa, has been extensively documented in several sys-
tems including cancer, metabolic diseases and stem cell biology
and some of these regulatory loops involve NRs. These miRNA-
mediated positive and negative feedback loops could be of physio-
logical relevance in NSCs [8]. MiRNA regulatory feedback loops
may further have consequences for neurodegenerative diseases
such as Huntington’s disease; the levels of several miRNAs respon-
sive to the REST transcription factor (speciﬁcally miR-9 and 9⁄)
were e.g. decreased in HD patients brain relative to healthycontrols. In turn, miR9/9⁄ control the expression of components
of the REST complex, conforming a mutual regulatory feedback
loop [35,36]. This may suggest that TLX, due to its ability to
regulate miR-9 expression in the mutual regulatory loop previ-
ously discussed, could be involved in the decrease in miR-9 expres-
sion observed in Huntington patient’s brain.
Interestingly, microRNA feedback loops have been linked to
other neurodegenerative diseases, such as Parkinson’s. Here, miR-
NA133b controls the transcription factor Pitx3 in an intrinsic regu-
latory feedback loop [37]. In C. elegans, the expression of the
Alzheimer’s amyloid precursor protein-like gene is regulated by
regulatory loops involving let-7 and its targets, the transcription
factors hbl-1 and lin-42, involved in developmental timing [38].
Moreover, recent observations have demonstrated that besides
expression regulation, miRNAs may be involved in the regulation
of alternative splicing of the amyloid precursor protein (APP)
mRNA, which affects b-amyloid peptide production. Interestingly,
a lack of miRNAs induced by ablation of Dicer in post-mitotic neu-
rons in vivo is associated with APP exons 7 and 8 inclusion, while
ectopic expression of miR-124 reversed these effects [39].
With respect to the mutual regulatory loop involving FXR and
miR-34a discussed in previous sections that may have signiﬁcant
effects on lipid and glucose metabolism [20], it is interesting to
note that the lipid proﬁle of the CNS is of considerable interest with
respect to neurodegenerative diseases. High levels of cholesterol
are present in the CNS (with cerebral cholesterol homeostasis
being altered in Alzheimer’s diease). Since some cholesterol
metabolites can act as ligands for nuclear receptors, this has raised
interest in their role in neurodegenerative disease, e.g. into the role
of LXR in Alzheimer’s disease [40]. Since miR-34a is known to mod-
ulate differentiation of stem cells, the identiﬁcation of the FXR/
miR-34a loop in NSCs could provide new avenues to control NSC
self-renewal and differentiation. Then, as a general remark, NR li-
gands may provide attractive pharmacological entry points to re-
place stem cell genetic reprogramming factors. Thus, NRs could
become important for drug discovery and cell replacement thera-
pies for neurodegenerative diseases.
The concept we highlight here is to some extent inspired by
observations done with the steroid hormone receptor EcR, that
incorporates nuclear receptors into miRNA regulatory feedback
loops (Fig. 1B). This allows for a cell-extrinsic coordination of the
regulatory feedback loops in vivo by endocrine/paracrine/auto-
crine active molecules. This implies that important cell-intrinsic
factors controlling stem cell self-renewal, fate and differentiation,
such as miRNAs, could be inﬂuenced, modulated and coordinated
in space and time by the extracellular environment through activa-
tion of NRs. In the developing CNS, subtypes of neurons and glial
cells are generated according to a schedule that is deﬁned by
cell-intrinsic and extrinsic mechanisms that function at the pro-
genitor-cell level [41]. Interestingly, during CNS development, the
NRs Coup-tfI and Coup-tfII, also known as Nr2f1 and Nr2f2, are re-
quired for the temporal speciﬁcation of neural stem/progenitor
cells [42]. This could provide a relevant system for validation of
the general relevance of regulatory loops involving NRs and miR-
NAs in NSC self-renewal and differentiation to neurons and other
neural cell types.
Regulatory loops between miRNAs and NR, explicitly demon-
strated in NSC, involve members of the orphan NR group, i.e TLX.
This has suggested that TLX may be involved in orchestrating
members of the miRNA signature (i.e. mir-9) [10] to control NSC
differentiation through precise transitions between neural progen-
itors and differentiated cells. Although speciﬁc regulatory feedback
loops involving NR for steroid hormones and miRNAs have not
been demonstrated unequivocally in NSC yet, mounting evidence
suggests that they may exist. Both GR and ER expression are
regulated by several miRNAs ([43] [44], and extensively reviewed
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multiple miRNAs [15,45].
Many steroid hormone receptors are expressed in adult NSC,
including GR and ER [46,47]. Although NSC self renewal and differ-
entiation are thought to be essentially cell-intrinsic processes, ste-
roid hormones and their cognate receptors may inﬂuence neural
NSC through the regulation of transcriptional and posttranscrip-
tional process in a cell-extrinsic fashion. Estrogens, via ER, affect
the proliferation and differentiation of NSC cells, probably acting
in conjunction with other extrinsic factors governing NSC develop-
ment [46]. In this respect, it could be very interesting to see if the
feedforward loop involving ER and miR-375 recently described in
human cancer cells [16], is expressed in NSCs and if so, which ef-
fect it could have on their proliferation/differentiation. On the
other hand, adrenal ‘‘stress’’ steroids (i.e glucocorticoids) are strong
inhibitors of adult neurogenesis, acting through the GR [48].
MiR-124, a key regulator of adult neurogenesis [33], negatively
regulates the expression of genes involved in NSC differentiation,
among which are components of the REST/SCP1 pathway and the
GR [34,43]. If effects of the GR on miR-124 expression in NSC could
be experimentally demonstrated, they would provide evidence for
the existence of new regulatory feedback loops involving miRNAs
and steroid receptors, with potential mechanistic and therapeutic
importance for NSCs and neurodegenerative diseases.5. Concluding remarks
In this article we have brieﬂy discussed the existence of regula-
tory feedback loops involving various miRNAs and NRs that could
have central physiological relevance, particularly in neural stem
cells. Recent evidence reviewed in this article suggests that these
loops could be more common than previously anticipated. Obvi-
ously, this concept together with its mechanistic and physiological
implications, await further experimental demonstration.
Initial attempts to apply stem cells to CNS tissue engineering re-
lied on intrinsic cellular properties of NSC. However, it is now
appreciated that the environment surrounding the cells plays an
indispensible role in regulating stem cell behavior. Therefore,
NRs could provide a therapeutic entry point to exploit regulatory
feedback loops with miRNAs involved in stem cell self-renewal
and determination. In this way, using known NRs ligands or small
molecules designed to mimic them, one could be able to instruct
endogenous or transplanted neural stem cells to respond or ignore
signals from the surrounding environment consequently beneﬁt-
ing speciﬁc tissue repair demands.
Thus, modulation of NR activity by pharmacological agents
could be applied in the future to reprogram stem cells, particularly
NSC, with strong implications for the future treatment of neurode-
generative disease.
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